Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2018 Volume 18 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2018 Volume 18 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Adoptive transfer of xenoantigen‑stimulated T cell receptor Vβ‑restricted human regulatory T cells prevents porcine islet xenograft rejection in humanized mice

  • Authors:
    • Xi Jin
    • Min Hu
    • Lina Gong
    • Huifang Li
    • Yan Wang
    • Ming Ji
    • Hong Li
  • View Affiliations / Copyright

    Affiliations: Institute of Urology, Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Centre for Transplant and Renal Research, Westmead Millennium Institute, University of Sydney, Westmead, NSW 2145, Australia, Cellular Biology Laboratory, Core Facility of West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Department of Physiology, School of Basic Medical Science, Central South University, Changsha, Hunan 410083, P.R. China
    Copyright: © Jin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4457-4467
    |
    Published online on: September 10, 2018
       https://doi.org/10.3892/mmr.2018.9471
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Polyclonal expansion of human regulatory T cells (Tregs) prevents xenogeneic rejection by suppressing effector T cell responses in vitro and in vivo. However, a major limitation to using polyclonally expanded Tregs is that they may cause pan‑immunosuppressive effects. The present study was conducted to compare the ability of ex vivo expanded human xenoantigen‑stimulated Tregs (Xeno‑Treg) and polyclonal Tregs (Poly‑Treg) to protect islet xenografts from rejection in NOD‑SCID interleukin (IL)‑2 receptor (IL2r)γ‑/‑ mice. Human cluster of differentiation (CD)4+CD25+CD127lo Tregs, expanded either by stimulating with porcine peripheral blood mononuclear cells (PBMCs) or anti‑CD3/CD28 beads, were characterized by immune cell phenotyping, T cell receptor (TCR) Vβ CDR3 spectratyping and performing suppressive activity assays in vitro. The efficiency of adoptively transferred ex vivo human Tregs was evaluated in vivo using neonatal porcine islet cell clusters (NICC) transplanted into NOD‑SCID IL‑2rγ‑/‑ mice, which received human PBMCs with or without Xeno‑Treg or Poly‑Treg. Xeno‑Treg, which expressed increased levels of human leukocyte antigen‑DR and secreted higher levels of IL‑10, demonstrated enhanced suppressive capacity in a pig‑human mixed lymphocyte reaction. Spectratypes of TCR Vβ4, Vβ10, Vβ18 and Vβ20 in Xeno‑Treg showed restriction and expanded clones at sizes of 205, 441, 332 and 196 respectively, compared to those of Poly‑Treg. Reconstitution of mice with human PBMCs and Poly‑Treg resulted in NICC xenograft rejection at 63 days. Adoptive transfer with human PBMCs and Xeno‑Treg prolonged islet xenograft survival beyond 84 days, with grafts containing intact insulin‑secreting cells surrounded by a small number of human CD45+ cells. This study demonstrated that adoptive transfer of ex vivo expanded human Xeno‑Treg may potently prevent islet xenograft rejection in humanized NOD‑SCID IL2rγ‑/‑ mice compared with Poly‑Treg. These findings suggested that adoptive Treg therapy may be used for immunomodulation in islet xenotransplantation by minimizing systemic immunosuppression.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

View References

1 

Vadori M and Cozzi E: The immunological barriers to xenotransplantation. Tissue Antigens. 86:239–253. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Butler JR, Wang ZY, Martens GR, Ladowski JM, Li P, Tector M and Tector AJ: Modified glycan models of pig-to-human xenotransplantation do not enhance the human-anti-pig T cell response. Transpl Immunol. 35:47–51. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Shin JS, Kim JM, Min BH, Yoon IH, Kim HJ, Kim JS, Kim YH, Kang SJ, Kim J, Kang HJ, et al: Pre-clinical results in pig-to-non-human primate islet xenotransplantation using anti-CD40 antibody (2C10R4)-based immunosuppression. Xenotransplantation. 25:2018. View Article : Google Scholar

4 

Lee JI, Kim J, Choi YJ, Park HJ, Park HJ, Wi HJ, Yoon S, Shin JS, Park JK, Jung KC, et al: The effect of epitope-based ligation of ICAM-1 on survival and retransplantation of pig islets in nonhuman primates. Xenotransplantation. 25:2018. View Article : Google Scholar

5 

Qiu F, Liu H, Liang CL, Nie GD and Dai Z: A new immunosuppressive molecule emodin induces both CD4+FoxP3+ and CD8+CD122+ regulatory T cells and suppresses murine allograft rejection. Front Immunol. 8:15192017. View Article : Google Scholar : PubMed/NCBI

6 

Garakani R and Saidi RF: Recent progress in cell therapy in solid organ transplantation. Int J Organ Transplant Med. 8:125–131. 2017.PubMed/NCBI

7 

Marek-Trzonkowska N, Myśliwiec M, Iwaszkiewicz-Grześ D, Gliwiński M, Derkowska I, Żalińska M, Zieliński M, Grabowska M, Zielińska H, Piekarska K, et al: Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes. J Transl Med. 14:3322016. View Article : Google Scholar : PubMed/NCBI

8 

Kasper IR, Apostolidis SA, Sharabi A and Tsokos GC: Empowering regulatory T cells in autoimmunity. Trends Mol Med. 22:784–797. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Lu L, Barbi J and Pan F: The regulation of immune tolerance by FOXP3. Nat Rev Immunol. 17:703–717. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Yi S, Ji M, Wu J, Ma X, Phillips P, Hawthorne WJ and O'Connell PJ: Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice. Diabetes. 61:1180–1191. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Jin X, Wang Y, Hawthorne WJ, Hu M, Yi S and O'Connell P: Enhanced suppression of the xenogeneic T-cell response in vitro by xenoantigen stimulated and expanded regulatory T cells. Transplantation. 97:30–38. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Dawson NAJ, Vent-Schmidt J and Levings MK: Engineered tolerance: Tailoring development, function, and antigen-specificity of regulatory T cells. Front Immunol. 8:14602017. View Article : Google Scholar : PubMed/NCBI

13 

Moore C, Tejon G, Fuentes C, Hidalgo Y, Bono MR, Maldonado P, Fernandez R, Wood KJ, Fierro JA, Rosemblatt M, et al: Alloreactive regulatory T cells generated with retinoic acid prevent skin allograft rejection. Eur J Immunol. 45:452–463. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Sagoo P, Lombardi G and Lechler RI: Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. Front Immunol. 3:1842012. View Article : Google Scholar : PubMed/NCBI

15 

The OLAW office of NIH, . Institutional animal care and use committee guidebook. 2nd. 2002

16 

Korbutt GS, Elliott JF, Ao Z, Smith DK, Warnock GL and Rajotte RV: Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest. 97:2119–2129. 1996. View Article : Google Scholar : PubMed/NCBI

17 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

18 

Walters G and Alexander SI: T cell receptor BV repertoires using real time PCR: A comparison of SYBR green and a dual-labelled HuTrec fluorescent probe. J Immunol Methods. 294:43–52. 2004. View Article : Google Scholar : PubMed/NCBI

19 

Yi S, Hawthorne WJ, Lehnert AM, Ha H, Wong JK, van Rooijen N, Davey K, Patel AT, Walters SN, Chandra A and O'Connell PJ: T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol. 170:2750–2758. 2003. View Article : Google Scholar : PubMed/NCBI

20 

Baecher-Allan C, Wolf E and Hafler DA: MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol. 176:4622–4631. 2006. View Article : Google Scholar : PubMed/NCBI

21 

Fountoulakis S, Vartholomatos G, Kolaitis N, Frillingos S, Philippou G and Tsatsoulis A: HLA-DR expressing peripheral T regulatory cells in newly diagnosed patients with different forms of autoimmune thyroid disease. Thyroid. 18:1195–1200. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Gagne K, Brouard S, Giral M, Sebille F, Moreau A, Guillet M, Bignon JD, Imbert BM, Cuturi MC and Soulillou JP: Highly altered V beta repertoire of T cells infiltrating long-term rejected kidney allografts. J Immunol. 164:1553–1563. 2000. View Article : Google Scholar : PubMed/NCBI

23 

Baron C, McMorrow I, Sachs DH and LeGuern C: Persistence of dominant T cell clones in accepted solid organ transplants. J Immunol. 167:4154–4160. 2001. View Article : Google Scholar : PubMed/NCBI

24 

Walters G, Habib AM, Reynolds J, Wu H, Knight JF and Pusey CD: Glomerular T cells are of restricted clonality and express multiple CDR3 motifs across different Vbeta T-cell receptor families in experimental autoimmune glomerulonephritis. Nephron Exp Nephrol. 98:e71–e81. 2004. View Article : Google Scholar : PubMed/NCBI

25 

Adair PR, Kim YC, Zhang AH, Yoon J and Scott DW: Human tregs made antigen specific by gene modification: The power to treat autoimmunity and antidrug antibodies with precision. Front Immunol. 8:11172017. View Article : Google Scholar : PubMed/NCBI

26 

Ma B, Yang JY, Song WJ, Ding R, Zhang ZC, Ji HC, Zhang X, Wang JL, Yang XS, Tao KS, et al: Combining exosomes derived from immature DCs with donor antigen-specific treg cells induces tolerance in a rat liver allograft model. Sci Rep. 6:329712016. View Article : Google Scholar : PubMed/NCBI

27 

Zheng J, Liu Y, Qin G, Chan PL, Mao H, Lam KT, Lewis DB, Lau YL and Tu W: Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells. J Immunol. 183:3742–3750. 2009. View Article : Google Scholar : PubMed/NCBI

28 

Veerapathran A, Pidala J, Beato F, Yu XZ and Anasetti C: Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly. Blood. 118:5671–5680. 2011. View Article : Google Scholar : PubMed/NCBI

29 

Cheraï M, Hamel Y, Baillou C, Touil S, Guillot-Delost M, Charlotte F, Kossir L, Simonin G, Maury S, Cohen JL and Lemoine FM: Generation of human alloantigen-specific regulatory T cells under good manufacturing practice-compliant conditions for cell therapy. Cell Transplant. 24:2527–2540. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Peters JH, Hilbrands LB, Koenen HJ and Joosten I: Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy. PLoS One. 3:e22332008. View Article : Google Scholar : PubMed/NCBI

31 

Boardman DA, Philippeos C, Fruhwirth GO, Ibrahim MA, Hannen RF, Cooper D, Marelli-Berg FM, Watt FM, Lechler RI, Maher J, et al: Expression of a chimeric antigen receptor specific for donor HLA class I enhances the potency of human regulatory T cells in preventing human skin transplant rejection. Am J Transplant. 17:931–943. 2017. View Article : Google Scholar : PubMed/NCBI

32 

Fozza C, Barraqueddu F, Corda G, Contini S, Virdis P, Dore F, Bonfigli S and Longinotti M: Study of the T-cell receptor repertoire by CDR3 spectratyping. J Immunol Methods. 440:1–11. 2017. View Article : Google Scholar : PubMed/NCBI

33 

Alvarez CM, Opelz G, Giraldo MC, Pelzl S, Renner F, Weimer R, Schmidt J, Arbeláez M, García LF and Süsal C: Evaluation of T-cell receptor repertoires in patients with long-term renal allograft survival. Am J Transplant. 5:746–756. 2005. View Article : Google Scholar : PubMed/NCBI

34 

Li M, Eckl J, Abicht JM, Mayr T, Reichart B, Schendel DJ and Pohla H: Induction of porcine-specific regulatory T cells with high specificity and expression of IL-10 and TGF-β1 using baboon-derived tolerogenic dendritic cells. Xenotransplantation. 25:2018. View Article : Google Scholar

35 

Li M, Eckl J, Geiger C, Schendel DJ and Pohla H: A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35. Sci Rep. 7:39742017. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Jin X, Hu M, Gong L, Li H, Wang Y, Ji M and Li H: Adoptive transfer of xenoantigen‑stimulated T cell receptor Vβ‑restricted human regulatory T cells prevents porcine islet xenograft rejection in humanized mice. Mol Med Rep 18: 4457-4467, 2018.
APA
Jin, X., Hu, M., Gong, L., Li, H., Wang, Y., Ji, M., & Li, H. (2018). Adoptive transfer of xenoantigen‑stimulated T cell receptor Vβ‑restricted human regulatory T cells prevents porcine islet xenograft rejection in humanized mice. Molecular Medicine Reports, 18, 4457-4467. https://doi.org/10.3892/mmr.2018.9471
MLA
Jin, X., Hu, M., Gong, L., Li, H., Wang, Y., Ji, M., Li, H."Adoptive transfer of xenoantigen‑stimulated T cell receptor Vβ‑restricted human regulatory T cells prevents porcine islet xenograft rejection in humanized mice". Molecular Medicine Reports 18.5 (2018): 4457-4467.
Chicago
Jin, X., Hu, M., Gong, L., Li, H., Wang, Y., Ji, M., Li, H."Adoptive transfer of xenoantigen‑stimulated T cell receptor Vβ‑restricted human regulatory T cells prevents porcine islet xenograft rejection in humanized mice". Molecular Medicine Reports 18, no. 5 (2018): 4457-4467. https://doi.org/10.3892/mmr.2018.9471
Copy and paste a formatted citation
x
Spandidos Publications style
Jin X, Hu M, Gong L, Li H, Wang Y, Ji M and Li H: Adoptive transfer of xenoantigen‑stimulated T cell receptor Vβ‑restricted human regulatory T cells prevents porcine islet xenograft rejection in humanized mice. Mol Med Rep 18: 4457-4467, 2018.
APA
Jin, X., Hu, M., Gong, L., Li, H., Wang, Y., Ji, M., & Li, H. (2018). Adoptive transfer of xenoantigen‑stimulated T cell receptor Vβ‑restricted human regulatory T cells prevents porcine islet xenograft rejection in humanized mice. Molecular Medicine Reports, 18, 4457-4467. https://doi.org/10.3892/mmr.2018.9471
MLA
Jin, X., Hu, M., Gong, L., Li, H., Wang, Y., Ji, M., Li, H."Adoptive transfer of xenoantigen‑stimulated T cell receptor Vβ‑restricted human regulatory T cells prevents porcine islet xenograft rejection in humanized mice". Molecular Medicine Reports 18.5 (2018): 4457-4467.
Chicago
Jin, X., Hu, M., Gong, L., Li, H., Wang, Y., Ji, M., Li, H."Adoptive transfer of xenoantigen‑stimulated T cell receptor Vβ‑restricted human regulatory T cells prevents porcine islet xenograft rejection in humanized mice". Molecular Medicine Reports 18, no. 5 (2018): 4457-4467. https://doi.org/10.3892/mmr.2018.9471
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team